BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11193442)

  • 1. [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia].
    Takagi K; Nakamura T; Misaki H; Ueda T
    Rinsho Ketsueki; 2000 Nov; 41(11):1214-9. PubMed ID: 11193442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia].
    Ikeda K; Mita M; Ishibashi T; Shichishima T; Maruyama Y
    Rinsho Ketsueki; 1998 Sep; 39(9):676-9. PubMed ID: 9796402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bilateral leg ulcers with pathologic evidence of small vessel vasculitis by skin biopsy during hydroxyurea therapy of chronic myelogenous leukemia].
    Tomiyama J; Yano K; Uchino S; Ito T; Kudo H; Irimajiri J; Ohkubo H; Kanazawa A; Kawahara Y
    Rinsho Ketsueki; 1997 Mar; 38(3):231-3. PubMed ID: 9095664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia].
    Watanabe N; Tani M; Tanaka Y; Kurata M; Matsushita A; Maeda A; Nagai K; Takahashi T
    Rinsho Ketsueki; 2004 Mar; 45(3):243-6. PubMed ID: 15103940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
    Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
    Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bilateral ankle ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia].
    Masuoka H; Kobayashi M; Kaito K; Yoshida M; Sekita T; Saeki A; Nishiwaki K; Shimada T; Ochiai S; Ootsubo H
    Rinsho Ketsueki; 1995 Feb; 36(2):156-8. PubMed ID: 7715088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
    Tripathi AK; Ahmad R; Sawlani KK
    J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea-induced fever in a patient with chronic myelogenous leukemia.
    Tsurumi H; Goto H; Hara T; Moriwaki H
    Int J Hematol; 2000 Oct; 72(3):386-7. PubMed ID: 11186000
    [No Abstract]   [Full Text] [Related]  

  • 10. Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
    Leo E; Krämer A; Hochhaus A; Krasniqi F; Hehlmann R; Ho AD
    Ann Hematol; 2002 Aug; 81(8):467-9. PubMed ID: 12224005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea.
    De Simone C; Guerriero C; Guidi B; Rotoli M; Venier A; Tartaglione R
    Eur J Dermatol; 1998 Mar; 8(2):114-5. PubMed ID: 9649662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pure red cell aplasia occurring during the course of chronic myelogenous leukemia].
    Yasuyama M; Kawauchi K; Takei K; Ogasawara T; Ohkawa S
    Rinsho Ketsueki; 2004 Jan; 45(1):66-71. PubMed ID: 14999937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous complications of long-term hydroxyurea therapy].
    Dem A; Diallo M; Gaye Fall MC; Dieng MM; Gaye M; Touré P
    Ann Dermatol Venereol; 2008 Nov; 135(11):800-1. PubMed ID: 19061670
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea induced leg ulcers.
    Abhyankar D; Shende C; Saikia T; Advani SH
    J Assoc Physicians India; 2000 Sep; 48(9):926-7. PubMed ID: 11198798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [beta-thalassemia minor diagnosed in a patient with chronic myelogenous leukemia during hydroxyurea therapy].
    Chiba K; Kurosawa M; Kondo T; Suzuki S; Musashi M; Asaka M; Imamura M; Hattori Y; Oba Y
    Rinsho Ketsueki; 2000 Jan; 41(1):61-4. PubMed ID: 10695401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple keratosis induced by hydroxyurea].
    Grange F; Couilliet D; Audhuy B; Krzisch S; Schlecht P; Guillaume JC
    Ann Dermatol Venereol; 1995; 122(1-2):16-8. PubMed ID: 7668775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin changes secondary to hydroxyurea therapy.
    Kennedy BJ; Smith LR; Goltz RW
    Arch Dermatol; 1975 Feb; 111(2):183-7. PubMed ID: 1054261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of bilateral heel ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia.
    Tarumoto T; Imagawa S; Hotta T; Ohmine K; Nagai T; Takatoku M; Komatsu N; Hatake K; Ozawa K
    Jpn J Clin Oncol; 2000 Mar; 30(3):159-62. PubMed ID: 10798544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Symmetrical foot ulcer in chronic myeloid leukemia treated with hydroxyurea (Litalir)].
    Reichenberger F
    Praxis (Bern 1994); 1998 Oct; 87(41):1370-2. PubMed ID: 9828669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.